Investing in small-cap health care companies can be tricky, with stocks that can soar or crash based on the results of a single clinical trial. However, equities.com's Small-Cap Stars, our proprietary list of small-cap companies with characteristics we've found to be most predictive of future success, isolates those companies that are best positioned to succeed.
Here are today's top performing health care Small-Cap Stars:
Fonar Corporation (FONR)
Fonar Corporation gained 17.46% to $13.39. The gains came on a volume of 309,501 shares against an average daily volume of 67,351 shares. Fonar Corporation has had a trading range from $27.95 to $5.12 over the last year, its P/E ratio is 6.2, it has a 50-day SMA of $11.75, and a 200-day SMA of $16.15.
Fonar Corp is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance Imaging (MRI) for the detection and diagnosis of human diseases.
Inovio Pharmaceuticals Inc. (INO)
Inovio Pharmaceuticals Inc. gained 10.37% to $9.58. The gains came on a volume of 1,956,800 shares against an average daily volume of 1,818,266 shares. Inovio Pharmaceuticals Inc. has had a trading range from $15.80 to $4.88 over the last year, it has a 50-day SMA of $10.10, and a 200-day SMA of $10.23.
Inovio Pharmaceuticals, Inc. is a biomedical company, engaged in the development of next-generation vaccines to prevent or treat cancers and chronic infectious diseases.
Horizon Pharma Inc. (HZNP)
Horizon Pharma Inc. gained 7.15% to $10.04. The gains came on a volume of 1,577,060 shares against an average daily volume of 2,490,459 shares. Horizon Pharma Inc. has had a trading range from $18.30 to $2.11 over the last year, it has a 50-day SMA of $13.61, and a 200-day SMA of $11.19.
Horizon Pharma Inc is a specialty pharmaceutical company. It has developed and is commercializing DUEXIS, VIMOVO and RAYOS/LODOTRA, each of which targets unmet therapeutic needs in arthritis, pain and inflammatory diseases.
Zeltiq Aesthetics Inc. (ZLTQ)
Zeltiq Aesthetics Inc. gained 6.91% to $20.10. The gains came on a volume of 607,001 shares against an average daily volume of 702,813 shares. Zeltiq Aesthetics Inc. has had a trading range from $24.79 to $6.67 over the last year, it has a 50-day SMA of $16.46, and a 200-day SMA of $17.58.
ZELTIQ Aesthetics Inc is a medical technology company. It develops and commercializes medical products such as CoolSculpting system which is a non-invasive product for the selective reduction of body fat.
Omeros Corporation (OMER)
Omeros Corporation gained 5.89% to $13.66. The gains came on a volume of 319,400 shares against an average daily volume of 311,371 shares. Omeros Corporation has had a trading range from $18.80 to $4.75 over the last year, it has a 50-day SMA of $14.59, and a 200-day SMA of $11.93.
Omeros Corp is engaged in the discovery, development and commercialization of pharmaceutical products for inflammation, coagulopathies and disorders of the central nervous system.
Equities.com's Health Care Small-Cap Stars - Helping You Build a Healthier Portfolio
No one can predict precisely which potential treatments will fly through their clinical trials and which will stumble along the way. At least, if someone can, they're undoubtedly spectacularly wealthy right now. But, while the science is clearly the most important factor for the success of a small-cap biotech company, it's not the only one.
Equities.com's Small-Cap Stars system uses a complicated statistical regression to determine which fundamental factors previous success stories had in common and then identifies those present health care small caps that share those traits. For health care companies, we found that a high enterprise value, a strong value line beta, and a high rate of reinvestment were among the most important qualities in predicting the potential success of a company.
All data provided by QuoteMedia and was accurate as of 4:30 pm ET.